Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Therapeutic drug monitoring should be performed in vulnerable populations, such as the elderly, children, and infants, to improve efficacy and reduce toxicity. Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. …”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Therapeutic drug monitoring should be performed in vulnerable populations, such as the elderly, children, and infants, to improve efficacy and reduce toxicity. Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. …”

Symptoms self-reported and/or documented in the electronic health record during the acute COVID-19 illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Data from population B analyzed for this report. by Birgit Deboutte (19452787)

“…Improved screening of parents by combining the VMBDD technique with the VDHE, significantly decreased LI and the prevalence of CHD in their offspring. …”

Data from population A analyzed for this report. by Birgit Deboutte (19452787)

“…Improved screening of parents by combining the VMBDD technique with the VDHE, significantly decreased LI and the prevalence of CHD in their offspring. …”

Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa. by Beatrice T. Nganso (4114768)

Subjects:

Pie charts showing the different patterns of risk factors associated with total colony losses by regions within Kenya by Beatrice T. Nganso (4114768)

Subjects:

SYRACLE’s risk of bias tool for the interventional studies of probiotics and prebiotics and Cochrane risk of bias tool for the clinical interventional studies. by Saiko Sugita (14581134)

Subjects:

Flow diagram of participant recruitment. by Sheng-Feng Lin (9591995)

Subjects:

Baseline characteristics of patients with prostate cancer and matched cohort. by Sheng-Feng Lin (9591995)

Subjects:

Adjusted association between accumulative exposure time and atopic diseases among men receiving GnRH analogues. by Sheng-Feng Lin (9591995)

Subjects:

Hazard ratios for atopic diseases in patients with prostate cancer during 3-year follow-up period. by Sheng-Feng Lin (9591995)

Subjects:

Cumulative incidence of atopic diseases. by Sheng-Feng Lin (9591995)

Subjects:

Association between soluble fiber intake and MetS Z-score. by Krista Lepping (13607649)

Association between insoluble fiber intake and MetS Z-score. by Krista Lepping (13607649)

Association between total fiber intake and MetS Z-score. by Krista Lepping (13607649)

Association between smoking status and incidence of cardiovascular and mortality outcomes stratified by enrollment year. by Erfan Tasdighi (9144667)

Subjects:

Baseline characteristics across conventional cigarette use status. by Erfan Tasdighi (9144667)

Subjects:

Graded association between pack-year groups in former and current smokers and cardiovascular and mortality outcomes. by Erfan Tasdighi (9144667)

Subjects:

Association between pack years of smoking and hazard ratio (HR) for CVD and mortality outcomes: a cubic spline analysis. by Erfan Tasdighi (9144667)

Subjects: